Sanara MedTech Inc. (SMTI)
SMTI moved a median of 0.00% 30 minutes after news, and -0.11% by the close. How SMTI actually reacts to news — the realized, point-in-time move the market made, measured across 277 labeled events over the last three years with zero look-ahead.
SMTI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 34% | 220 |
| 30-min | 0.00% | 50% | 251 |
| 60-min | +0.03% | 51% | 261 |
| to close | -0.11% | 47% | 276 |
| Middle 50% of SMTI reactions | -0.95% to +1.08% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 277 |
Half of all Sanara MedTech Inc. news events land between -0.95% and +1.08% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How SMTI reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 13 | +0.35% | 62% | +0.47% |
| Rating reiterations | 19 | +0.41% | 68% | +1.07% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how SMTI ranks against every other measured name →
That’s how SMTI usually reacts — get an email when it moves on news →Email me when SMTI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SMTI's baseline. Nothing else.
Recent SMTI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Sanara MedTech Inc. For: Oct 15 | SEC filing · Form 8-K | SEC EDGAR | -1.63% | -5.23% | |
| Form 8-K Sanara MedTech Inc. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.54% | |
| Form DEFM14A Sanara MedTech Inc. | SEC filing · Form DEFM14A | SEC EDGAR | +0.06% | +1.04% | |
| SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.00% | +0.84% | |
| Form 10-Q Sanara MedTech Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.23% | +0.23% | |
| Form 8-K Sanara MedTech Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | +0.23% | +0.23% | |
| Form 8-K/A Sanara MedTech Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +0.23% | +0.23% | |
| Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | Press release | GlobeNewswire | +0.23% | +0.23% | |
| Form 8-K Sanara MedTech Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +1.09% | +1.89% | |
| SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +1.09% | +1.89% | |
| Form 8-K Sanara MedTech Inc. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.04% | |
| Form 8-K Sanara MedTech Inc. For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | +0.82% | +2.47% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | -1.21% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | -0.43% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | — | +1.96% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sanara MedTech Inc. (SMTI) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | -0.04% | |
| Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | +3.11% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.86% | -1.98% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | -0.27% | -8.38% | |
| Form 10-Q Sanara MedTech Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +6.42% | +2.98% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | -1.53% | |
| Form 8-K Sanara MedTech Inc. For: May 11 | SEC filing · Form 8-K | SEC EDGAR | -7.45% | -7.76% | |
| Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) | Press release | GlobeNewswire | -7.45% | -7.76% | |
| Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +3.26% | -2.06% | |
| Form ARS Sanara MedTech Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.79% | +2.98% | |
| Form DEF 14A Sanara MedTech Inc. For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | +0.79% | +2.98% | |
| Form DEFA14A Sanara MedTech Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.79% | +2.98% | |
| Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 | Press release | GlobeNewswire | -1.09% | +5.95% | |
| Form 10-K Sanara MedTech Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.43% | -9.92% | |
| Form 8-K Sanara MedTech Inc. For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | -1.66% | -0.11% | |
| Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance | Press release | GlobeNewswire | -1.66% | -0.11% | |
| Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds | Press release | GlobeNewswire | +0.10% | -1.56% | |
| Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 | Press release | GlobeNewswire | -1.09% | +3.02% | |
| Form 8-K Sanara MedTech Inc. For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | -1.09% | +3.02% | |
| Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd | Press release | GlobeNewswire | -0.16% | +1.27% | |
| Form 8-K Sanara MedTech Inc. For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.23% | |
| Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance | Press release | GlobeNewswire | +0.00% | -0.23% | |
| Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution | Press release | GlobeNewswire | +0.04% | +0.68% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech, Inc. (SMTI) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +1.11% | -5.36% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sanara MedTech, Inc. (SMTI) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | -1.09% | -2.41% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc. (SMTI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | -0.73% | |
| Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™ | Press release | GlobeNewswire | +1.27% | +2.95% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc. (SMTI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | -3.29% | |
| Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | -0.73% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech, Inc. (SMTI) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.29% | +1.54% | |
| Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.61% | -1.92% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sanara MedTech, Inc. (SMTI) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | -0.83% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc. (SMTI) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.58% | -1.41% | |
| Form 8-K Sanara MedTech Inc. For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | — | +0.43% | |
| Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd | Press release | GlobeNewswire | +0.00% | -8.45% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SMTI section they belong to.
Where else SMTI is measured.
SMTI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Sanara MedTech Inc.'s median reaction calculated?
Every labeled SMTI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 277 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of SMTI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SMTI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.